nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—germ cell cancer—uterine cancer	0.543	1	CtDrD
Ifosfamide—CYP2A6—Progesterone—uterine cancer	0.0435	0.141	CbGbCtD
Ifosfamide—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0324	0.105	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0297	0.0966	CbGbCtD
Ifosfamide—CYP3A7—Progesterone—uterine cancer	0.0297	0.0966	CbGbCtD
Ifosfamide—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0226	0.0734	CbGbCtD
Ifosfamide—CYP3A5—Progesterone—uterine cancer	0.0223	0.0725	CbGbCtD
Ifosfamide—CYP2C8—Progesterone—uterine cancer	0.0215	0.0697	CbGbCtD
Ifosfamide—CYP2C19—Progesterone—uterine cancer	0.018	0.0584	CbGbCtD
Ifosfamide—PTGS1—Etoposide—uterine cancer	0.0166	0.054	CbGbCtD
Ifosfamide—CYP2C9—Progesterone—uterine cancer	0.015	0.0486	CbGbCtD
Ifosfamide—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0131	0.0427	CbGbCtD
Ifosfamide—CYP3A5—Etoposide—uterine cancer	0.00999	0.0324	CbGbCtD
Ifosfamide—CYP2C8—Etoposide—uterine cancer	0.0096	0.0312	CbGbCtD
Ifosfamide—CYP3A4—Progesterone—uterine cancer	0.0087	0.0283	CbGbCtD
Ifosfamide—CYP2B6—Doxorubicin—uterine cancer	0.00865	0.0281	CbGbCtD
Ifosfamide—CYP3A4—Etoposide—uterine cancer	0.00389	0.0126	CbGbCtD
Ifosfamide—CYP3A4—Doxorubicin—uterine cancer	0.00266	0.00862	CbGbCtD
Ifosfamide—PTGS1—oviduct—uterine cancer	0.000462	0.102	CbGeAlD
Ifosfamide—CYP2C18—uterine cervix—uterine cancer	0.000382	0.0848	CbGeAlD
Ifosfamide—CYP2C18—mammalian vulva—uterine cancer	0.000334	0.0742	CbGeAlD
Ifosfamide—PTGS1—artery—uterine cancer	0.000306	0.0678	CbGeAlD
Ifosfamide—CYP2C18—vagina—uterine cancer	0.000259	0.0574	CbGeAlD
Ifosfamide—CYP2A6—vagina—uterine cancer	0.000171	0.038	CbGeAlD
Ifosfamide—CYP2C8—renal system—uterine cancer	0.000133	0.0294	CbGeAlD
Ifosfamide—CYP2C8—endometrium—uterine cancer	0.000128	0.0284	CbGeAlD
Ifosfamide—CYP3A5—uterine cervix—uterine cancer	0.000128	0.0284	CbGeAlD
Ifosfamide—CYP3A5—renal system—uterine cancer	0.00012	0.0266	CbGeAlD
Ifosfamide—CYP2B6—renal system—uterine cancer	0.000119	0.0264	CbGeAlD
Ifosfamide—PTGS1—epithelium—uterine cancer	0.000116	0.0257	CbGeAlD
Ifosfamide—PTGS1—uterine cervix—uterine cancer	0.000115	0.0255	CbGeAlD
Ifosfamide—PTGS1—smooth muscle tissue—uterine cancer	0.000112	0.0248	CbGeAlD
Ifosfamide—CYP2C19—vagina—uterine cancer	0.00011	0.0244	CbGeAlD
Ifosfamide—PTGS1—renal system—uterine cancer	0.000108	0.0239	CbGeAlD
Ifosfamide—CYP2C8—female reproductive system—uterine cancer	0.000106	0.0236	CbGeAlD
Ifosfamide—PTGS1—endometrium—uterine cancer	0.000104	0.0231	CbGeAlD
Ifosfamide—PTGS1—mammalian vulva—uterine cancer	0.000101	0.0223	CbGeAlD
Ifosfamide—CYP2C8—vagina—uterine cancer	9.6e-05	0.0213	CbGeAlD
Ifosfamide—PTGS1—uterus—uterine cancer	9.58e-05	0.0213	CbGeAlD
Ifosfamide—CYP2B6—female reproductive system—uterine cancer	9.52e-05	0.0211	CbGeAlD
Ifosfamide—CYP2C9—female reproductive system—uterine cancer	9.43e-05	0.0209	CbGeAlD
Ifosfamide—CYP3A4—renal system—uterine cancer	8.98e-05	0.0199	CbGeAlD
Ifosfamide—CYP3A5—female gonad—uterine cancer	8.72e-05	0.0193	CbGeAlD
Ifosfamide—CYP3A5—vagina—uterine cancer	8.67e-05	0.0192	CbGeAlD
Ifosfamide—CYP2B6—vagina—uterine cancer	8.61e-05	0.0191	CbGeAlD
Ifosfamide—PTGS1—female reproductive system—uterine cancer	8.61e-05	0.0191	CbGeAlD
Ifosfamide—PTGS1—female gonad—uterine cancer	7.83e-05	0.0174	CbGeAlD
Ifosfamide—PTGS1—vagina—uterine cancer	7.79e-05	0.0173	CbGeAlD
Ifosfamide—CYP3A4—female reproductive system—uterine cancer	7.19e-05	0.016	CbGeAlD
Ifosfamide—Renal failure acute—Doxorubicin—uterine cancer	6.31e-05	0.000471	CcSEcCtD
Ifosfamide—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	6.3e-05	0.00047	CcSEcCtD
Ifosfamide—Osteoarthritis—Epirubicin—uterine cancer	6.3e-05	0.00047	CcSEcCtD
Ifosfamide—Pain in extremity—Epirubicin—uterine cancer	6.3e-05	0.00047	CcSEcCtD
Ifosfamide—Feeling abnormal—Dactinomycin—uterine cancer	6.29e-05	0.000469	CcSEcCtD
Ifosfamide—Ill-defined disorder—Etoposide—uterine cancer	6.28e-05	0.000468	CcSEcCtD
Ifosfamide—Anaemia—Etoposide—uterine cancer	6.25e-05	0.000466	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Dactinomycin—uterine cancer	6.24e-05	0.000465	CcSEcCtD
Ifosfamide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	6.22e-05	0.000464	CcSEcCtD
Ifosfamide—Rash—Medroxyprogesterone Acetate—uterine cancer	6.17e-05	0.00046	CcSEcCtD
Ifosfamide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	6.16e-05	0.000459	CcSEcCtD
Ifosfamide—Renal impairment—Doxorubicin—uterine cancer	6.12e-05	0.000456	CcSEcCtD
Ifosfamide—Malaise—Etoposide—uterine cancer	6.1e-05	0.000455	CcSEcCtD
Ifosfamide—Vertigo—Etoposide—uterine cancer	6.08e-05	0.000453	CcSEcCtD
Ifosfamide—Leukopenia—Etoposide—uterine cancer	6.06e-05	0.000452	CcSEcCtD
Ifosfamide—Body temperature increased—Dactinomycin—uterine cancer	6.03e-05	0.00045	CcSEcCtD
Ifosfamide—Abdominal pain—Dactinomycin—uterine cancer	6.03e-05	0.00045	CcSEcCtD
Ifosfamide—Cardiac arrest—Epirubicin—uterine cancer	5.99e-05	0.000446	CcSEcCtD
Ifosfamide—Cardiac failure—Doxorubicin—uterine cancer	5.97e-05	0.000445	CcSEcCtD
Ifosfamide—Cough—Etoposide—uterine cancer	5.9e-05	0.00044	CcSEcCtD
Ifosfamide—Blood creatinine increased—Epirubicin—uterine cancer	5.9e-05	0.00044	CcSEcCtD
Ifosfamide—Convulsion—Etoposide—uterine cancer	5.86e-05	0.000437	CcSEcCtD
Ifosfamide—Hypertension—Etoposide—uterine cancer	5.84e-05	0.000436	CcSEcCtD
Ifosfamide—Pain in extremity—Doxorubicin—uterine cancer	5.83e-05	0.000434	CcSEcCtD
Ifosfamide—Osteoarthritis—Doxorubicin—uterine cancer	5.83e-05	0.000434	CcSEcCtD
Ifosfamide—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	5.83e-05	0.000434	CcSEcCtD
Ifosfamide—Nausea—Medroxyprogesterone Acetate—uterine cancer	5.81e-05	0.000433	CcSEcCtD
Ifosfamide—Chest pain—Etoposide—uterine cancer	5.76e-05	0.000429	CcSEcCtD
Ifosfamide—Hypokalaemia—Epirubicin—uterine cancer	5.73e-05	0.000427	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	5.72e-05	0.000426	CcSEcCtD
Ifosfamide—Discomfort—Etoposide—uterine cancer	5.69e-05	0.000424	CcSEcCtD
Ifosfamide—Breast disorder—Epirubicin—uterine cancer	5.69e-05	0.000424	CcSEcCtD
Ifosfamide—Toxic epidermal necrolysis—Epirubicin—uterine cancer	5.67e-05	0.000423	CcSEcCtD
Ifosfamide—Hypersensitivity—Dactinomycin—uterine cancer	5.62e-05	0.000419	CcSEcCtD
Ifosfamide—Confusional state—Etoposide—uterine cancer	5.57e-05	0.000415	CcSEcCtD
Ifosfamide—Cardiac arrest—Doxorubicin—uterine cancer	5.54e-05	0.000413	CcSEcCtD
Ifosfamide—Anaphylactic shock—Etoposide—uterine cancer	5.52e-05	0.000412	CcSEcCtD
Ifosfamide—Infection—Etoposide—uterine cancer	5.49e-05	0.000409	CcSEcCtD
Ifosfamide—Asthenia—Dactinomycin—uterine cancer	5.47e-05	0.000408	CcSEcCtD
Ifosfamide—Blood creatinine increased—Doxorubicin—uterine cancer	5.46e-05	0.000407	CcSEcCtD
Ifosfamide—Thrombocytopenia—Etoposide—uterine cancer	5.41e-05	0.000403	CcSEcCtD
Ifosfamide—Skin disorder—Etoposide—uterine cancer	5.36e-05	0.0004	CcSEcCtD
Ifosfamide—Hyperhidrosis—Etoposide—uterine cancer	5.34e-05	0.000398	CcSEcCtD
Ifosfamide—Pancreatitis—Epirubicin—uterine cancer	5.34e-05	0.000398	CcSEcCtD
Ifosfamide—Hypokalaemia—Doxorubicin—uterine cancer	5.3e-05	0.000395	CcSEcCtD
Ifosfamide—Angina pectoris—Epirubicin—uterine cancer	5.3e-05	0.000395	CcSEcCtD
Ifosfamide—Breast disorder—Doxorubicin—uterine cancer	5.27e-05	0.000393	CcSEcCtD
Ifosfamide—Anorexia—Etoposide—uterine cancer	5.26e-05	0.000392	CcSEcCtD
Ifosfamide—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	5.25e-05	0.000391	CcSEcCtD
Ifosfamide—Diarrhoea—Dactinomycin—uterine cancer	5.22e-05	0.000389	CcSEcCtD
Ifosfamide—Pancytopenia—Epirubicin—uterine cancer	5.17e-05	0.000385	CcSEcCtD
Ifosfamide—Hypotension—Etoposide—uterine cancer	5.16e-05	0.000385	CcSEcCtD
Ifosfamide—Dysuria—Epirubicin—uterine cancer	5.09e-05	0.000379	CcSEcCtD
Ifosfamide—PTGS1—lymph node—uterine cancer	5.04e-05	0.0112	CbGeAlD
Ifosfamide—Pollakiuria—Epirubicin—uterine cancer	5.03e-05	0.000375	CcSEcCtD
Ifosfamide—Paraesthesia—Etoposide—uterine cancer	4.96e-05	0.00037	CcSEcCtD
Ifosfamide—Pancreatitis—Doxorubicin—uterine cancer	4.94e-05	0.000368	CcSEcCtD
Ifosfamide—Dyspnoea—Etoposide—uterine cancer	4.92e-05	0.000367	CcSEcCtD
Ifosfamide—Hyperglycaemia—Epirubicin—uterine cancer	4.91e-05	0.000366	CcSEcCtD
Ifosfamide—Somnolence—Etoposide—uterine cancer	4.91e-05	0.000366	CcSEcCtD
Ifosfamide—Angina pectoris—Doxorubicin—uterine cancer	4.91e-05	0.000366	CcSEcCtD
Ifosfamide—Pneumonia—Epirubicin—uterine cancer	4.88e-05	0.000364	CcSEcCtD
Ifosfamide—Infestation NOS—Epirubicin—uterine cancer	4.85e-05	0.000362	CcSEcCtD
Ifosfamide—Infestation—Epirubicin—uterine cancer	4.85e-05	0.000362	CcSEcCtD
Ifosfamide—Vomiting—Dactinomycin—uterine cancer	4.85e-05	0.000362	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Epirubicin—uterine cancer	4.81e-05	0.000359	CcSEcCtD
Ifosfamide—Rash—Dactinomycin—uterine cancer	4.81e-05	0.000359	CcSEcCtD
Ifosfamide—Decreased appetite—Etoposide—uterine cancer	4.8e-05	0.000358	CcSEcCtD
Ifosfamide—Pancytopenia—Doxorubicin—uterine cancer	4.78e-05	0.000357	CcSEcCtD
Ifosfamide—Renal failure—Epirubicin—uterine cancer	4.77e-05	0.000356	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Etoposide—uterine cancer	4.77e-05	0.000355	CcSEcCtD
Ifosfamide—Fatigue—Etoposide—uterine cancer	4.76e-05	0.000355	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Epirubicin—uterine cancer	4.76e-05	0.000355	CcSEcCtD
Ifosfamide—Stomatitis—Epirubicin—uterine cancer	4.73e-05	0.000353	CcSEcCtD
Ifosfamide—Pain—Etoposide—uterine cancer	4.72e-05	0.000352	CcSEcCtD
Ifosfamide—Constipation—Etoposide—uterine cancer	4.72e-05	0.000352	CcSEcCtD
Ifosfamide—Conjunctivitis—Epirubicin—uterine cancer	4.72e-05	0.000352	CcSEcCtD
Ifosfamide—Dysuria—Doxorubicin—uterine cancer	4.71e-05	0.000351	CcSEcCtD
Ifosfamide—Pollakiuria—Doxorubicin—uterine cancer	4.65e-05	0.000347	CcSEcCtD
Ifosfamide—Haematuria—Epirubicin—uterine cancer	4.63e-05	0.000345	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Epirubicin—uterine cancer	4.59e-05	0.000342	CcSEcCtD
Ifosfamide—Feeling abnormal—Etoposide—uterine cancer	4.55e-05	0.000339	CcSEcCtD
Ifosfamide—Hyperglycaemia—Doxorubicin—uterine cancer	4.54e-05	0.000339	CcSEcCtD
Ifosfamide—Nausea—Dactinomycin—uterine cancer	4.53e-05	0.000338	CcSEcCtD
Ifosfamide—Agranulocytosis—Epirubicin—uterine cancer	4.53e-05	0.000338	CcSEcCtD
Ifosfamide—Pneumonia—Doxorubicin—uterine cancer	4.52e-05	0.000337	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Etoposide—uterine cancer	4.52e-05	0.000337	CcSEcCtD
Ifosfamide—Infestation NOS—Doxorubicin—uterine cancer	4.49e-05	0.000335	CcSEcCtD
Ifosfamide—Infestation—Doxorubicin—uterine cancer	4.49e-05	0.000335	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	4.45e-05	0.000332	CcSEcCtD
Ifosfamide—Bradycardia—Epirubicin—uterine cancer	4.44e-05	0.000331	CcSEcCtD
Ifosfamide—Renal failure—Doxorubicin—uterine cancer	4.41e-05	0.000329	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Doxorubicin—uterine cancer	4.4e-05	0.000328	CcSEcCtD
Ifosfamide—Urticaria—Etoposide—uterine cancer	4.39e-05	0.000327	CcSEcCtD
Ifosfamide—Haemoglobin—Epirubicin—uterine cancer	4.38e-05	0.000326	CcSEcCtD
Ifosfamide—Stomatitis—Doxorubicin—uterine cancer	4.38e-05	0.000326	CcSEcCtD
Ifosfamide—Abdominal pain—Etoposide—uterine cancer	4.37e-05	0.000325	CcSEcCtD
Ifosfamide—Body temperature increased—Etoposide—uterine cancer	4.37e-05	0.000325	CcSEcCtD
Ifosfamide—Conjunctivitis—Doxorubicin—uterine cancer	4.37e-05	0.000325	CcSEcCtD
Ifosfamide—Haemorrhage—Epirubicin—uterine cancer	4.36e-05	0.000325	CcSEcCtD
Ifosfamide—Hepatitis—Epirubicin—uterine cancer	4.36e-05	0.000325	CcSEcCtD
Ifosfamide—Urinary tract disorder—Epirubicin—uterine cancer	4.3e-05	0.000321	CcSEcCtD
Ifosfamide—Haematuria—Doxorubicin—uterine cancer	4.28e-05	0.000319	CcSEcCtD
Ifosfamide—Connective tissue disorder—Epirubicin—uterine cancer	4.28e-05	0.000319	CcSEcCtD
Ifosfamide—Urethral disorder—Epirubicin—uterine cancer	4.27e-05	0.000318	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Doxorubicin—uterine cancer	4.25e-05	0.000317	CcSEcCtD
Ifosfamide—Visual impairment—Epirubicin—uterine cancer	4.2e-05	0.000313	CcSEcCtD
Ifosfamide—Agranulocytosis—Doxorubicin—uterine cancer	4.19e-05	0.000312	CcSEcCtD
Ifosfamide—Erythema multiforme—Epirubicin—uterine cancer	4.12e-05	0.000307	CcSEcCtD
Ifosfamide—Bradycardia—Doxorubicin—uterine cancer	4.1e-05	0.000306	CcSEcCtD
Ifosfamide—Eye disorder—Epirubicin—uterine cancer	4.07e-05	0.000304	CcSEcCtD
Ifosfamide—Hypersensitivity—Etoposide—uterine cancer	4.07e-05	0.000303	CcSEcCtD
Ifosfamide—Tinnitus—Epirubicin—uterine cancer	4.06e-05	0.000303	CcSEcCtD
Ifosfamide—Haemoglobin—Doxorubicin—uterine cancer	4.05e-05	0.000302	CcSEcCtD
Ifosfamide—Flushing—Epirubicin—uterine cancer	4.04e-05	0.000301	CcSEcCtD
Ifosfamide—Cardiac disorder—Epirubicin—uterine cancer	4.04e-05	0.000301	CcSEcCtD
Ifosfamide—Haemorrhage—Doxorubicin—uterine cancer	4.03e-05	0.000301	CcSEcCtD
Ifosfamide—Hepatitis—Doxorubicin—uterine cancer	4.03e-05	0.000301	CcSEcCtD
Ifosfamide—Urinary tract disorder—Doxorubicin—uterine cancer	3.98e-05	0.000297	CcSEcCtD
Ifosfamide—Asthenia—Etoposide—uterine cancer	3.96e-05	0.000295	CcSEcCtD
Ifosfamide—Connective tissue disorder—Doxorubicin—uterine cancer	3.96e-05	0.000295	CcSEcCtD
Ifosfamide—Angiopathy—Epirubicin—uterine cancer	3.95e-05	0.000295	CcSEcCtD
Ifosfamide—Urethral disorder—Doxorubicin—uterine cancer	3.95e-05	0.000295	CcSEcCtD
Ifosfamide—Immune system disorder—Epirubicin—uterine cancer	3.94e-05	0.000293	CcSEcCtD
Ifosfamide—Mediastinal disorder—Epirubicin—uterine cancer	3.93e-05	0.000293	CcSEcCtD
Ifosfamide—Chills—Epirubicin—uterine cancer	3.91e-05	0.000291	CcSEcCtD
Ifosfamide—Pruritus—Etoposide—uterine cancer	3.91e-05	0.000291	CcSEcCtD
Ifosfamide—Arrhythmia—Epirubicin—uterine cancer	3.89e-05	0.00029	CcSEcCtD
Ifosfamide—Visual impairment—Doxorubicin—uterine cancer	3.89e-05	0.00029	CcSEcCtD
Ifosfamide—Alopecia—Epirubicin—uterine cancer	3.85e-05	0.000287	CcSEcCtD
Ifosfamide—Mental disorder—Epirubicin—uterine cancer	3.82e-05	0.000285	CcSEcCtD
Ifosfamide—Erythema multiforme—Doxorubicin—uterine cancer	3.81e-05	0.000284	CcSEcCtD
Ifosfamide—Malnutrition—Epirubicin—uterine cancer	3.79e-05	0.000283	CcSEcCtD
Ifosfamide—Erythema—Epirubicin—uterine cancer	3.79e-05	0.000283	CcSEcCtD
Ifosfamide—Diarrhoea—Etoposide—uterine cancer	3.78e-05	0.000282	CcSEcCtD
Ifosfamide—Eye disorder—Doxorubicin—uterine cancer	3.77e-05	0.000281	CcSEcCtD
Ifosfamide—Tinnitus—Doxorubicin—uterine cancer	3.76e-05	0.00028	CcSEcCtD
Ifosfamide—Flushing—Doxorubicin—uterine cancer	3.74e-05	0.000279	CcSEcCtD
Ifosfamide—Cardiac disorder—Doxorubicin—uterine cancer	3.74e-05	0.000279	CcSEcCtD
Ifosfamide—Angiopathy—Doxorubicin—uterine cancer	3.66e-05	0.000273	CcSEcCtD
Ifosfamide—Dizziness—Etoposide—uterine cancer	3.65e-05	0.000272	CcSEcCtD
Ifosfamide—Immune system disorder—Doxorubicin—uterine cancer	3.64e-05	0.000271	CcSEcCtD
Ifosfamide—Mediastinal disorder—Doxorubicin—uterine cancer	3.63e-05	0.000271	CcSEcCtD
Ifosfamide—Chills—Doxorubicin—uterine cancer	3.62e-05	0.00027	CcSEcCtD
Ifosfamide—Arrhythmia—Doxorubicin—uterine cancer	3.6e-05	0.000268	CcSEcCtD
Ifosfamide—Vision blurred—Epirubicin—uterine cancer	3.57e-05	0.000266	CcSEcCtD
Ifosfamide—Alopecia—Doxorubicin—uterine cancer	3.56e-05	0.000266	CcSEcCtD
Ifosfamide—Mental disorder—Doxorubicin—uterine cancer	3.53e-05	0.000263	CcSEcCtD
Ifosfamide—Ill-defined disorder—Epirubicin—uterine cancer	3.52e-05	0.000262	CcSEcCtD
Ifosfamide—Vomiting—Etoposide—uterine cancer	3.51e-05	0.000262	CcSEcCtD
Ifosfamide—Malnutrition—Doxorubicin—uterine cancer	3.51e-05	0.000262	CcSEcCtD
Ifosfamide—Erythema—Doxorubicin—uterine cancer	3.51e-05	0.000262	CcSEcCtD
Ifosfamide—Anaemia—Epirubicin—uterine cancer	3.51e-05	0.000261	CcSEcCtD
Ifosfamide—Agitation—Epirubicin—uterine cancer	3.49e-05	0.00026	CcSEcCtD
Ifosfamide—Rash—Etoposide—uterine cancer	3.48e-05	0.00026	CcSEcCtD
Ifosfamide—Dermatitis—Etoposide—uterine cancer	3.48e-05	0.000259	CcSEcCtD
Ifosfamide—Malaise—Epirubicin—uterine cancer	3.42e-05	0.000255	CcSEcCtD
Ifosfamide—Vertigo—Epirubicin—uterine cancer	3.41e-05	0.000254	CcSEcCtD
Ifosfamide—Leukopenia—Epirubicin—uterine cancer	3.4e-05	0.000253	CcSEcCtD
Ifosfamide—Palpitations—Epirubicin—uterine cancer	3.35e-05	0.00025	CcSEcCtD
Ifosfamide—Cough—Epirubicin—uterine cancer	3.31e-05	0.000247	CcSEcCtD
Ifosfamide—Vision blurred—Doxorubicin—uterine cancer	3.31e-05	0.000247	CcSEcCtD
Ifosfamide—Convulsion—Epirubicin—uterine cancer	3.29e-05	0.000245	CcSEcCtD
Ifosfamide—Nausea—Etoposide—uterine cancer	3.28e-05	0.000245	CcSEcCtD
Ifosfamide—Hypertension—Epirubicin—uterine cancer	3.27e-05	0.000244	CcSEcCtD
Ifosfamide—Ill-defined disorder—Doxorubicin—uterine cancer	3.26e-05	0.000243	CcSEcCtD
Ifosfamide—Anaemia—Doxorubicin—uterine cancer	3.24e-05	0.000242	CcSEcCtD
Ifosfamide—Arthralgia—Epirubicin—uterine cancer	3.23e-05	0.000241	CcSEcCtD
Ifosfamide—Chest pain—Epirubicin—uterine cancer	3.23e-05	0.000241	CcSEcCtD
Ifosfamide—Myalgia—Epirubicin—uterine cancer	3.23e-05	0.000241	CcSEcCtD
Ifosfamide—Agitation—Doxorubicin—uterine cancer	3.23e-05	0.00024	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	3.21e-05	0.000239	CcSEcCtD
Ifosfamide—Discomfort—Epirubicin—uterine cancer	3.19e-05	0.000238	CcSEcCtD
Ifosfamide—Malaise—Doxorubicin—uterine cancer	3.16e-05	0.000236	CcSEcCtD
Ifosfamide—Vertigo—Doxorubicin—uterine cancer	3.15e-05	0.000235	CcSEcCtD
Ifosfamide—Leukopenia—Doxorubicin—uterine cancer	3.14e-05	0.000234	CcSEcCtD
Ifosfamide—Confusional state—Epirubicin—uterine cancer	3.12e-05	0.000233	CcSEcCtD
Ifosfamide—Palpitations—Doxorubicin—uterine cancer	3.1e-05	0.000231	CcSEcCtD
Ifosfamide—Anaphylactic shock—Epirubicin—uterine cancer	3.1e-05	0.000231	CcSEcCtD
Ifosfamide—Oedema—Epirubicin—uterine cancer	3.1e-05	0.000231	CcSEcCtD
Ifosfamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	3.08e-05	0.00299	CbGpPWpGaD
Ifosfamide—Infection—Epirubicin—uterine cancer	3.08e-05	0.000229	CcSEcCtD
Ifosfamide—Cough—Doxorubicin—uterine cancer	3.06e-05	0.000228	CcSEcCtD
Ifosfamide—Convulsion—Doxorubicin—uterine cancer	3.04e-05	0.000227	CcSEcCtD
Ifosfamide—Nervous system disorder—Epirubicin—uterine cancer	3.04e-05	0.000226	CcSEcCtD
Ifosfamide—Thrombocytopenia—Epirubicin—uterine cancer	3.03e-05	0.000226	CcSEcCtD
Ifosfamide—Hypertension—Doxorubicin—uterine cancer	3.03e-05	0.000226	CcSEcCtD
Ifosfamide—CYP2B6—Metapathway biotransformation—AKR1C3—uterine cancer	3.01e-05	0.00292	CbGpPWpGaD
Ifosfamide—Skin disorder—Epirubicin—uterine cancer	3.01e-05	0.000224	CcSEcCtD
Ifosfamide—Hyperhidrosis—Epirubicin—uterine cancer	2.99e-05	0.000223	CcSEcCtD
Ifosfamide—Chest pain—Doxorubicin—uterine cancer	2.99e-05	0.000223	CcSEcCtD
Ifosfamide—Arthralgia—Doxorubicin—uterine cancer	2.99e-05	0.000223	CcSEcCtD
Ifosfamide—Myalgia—Doxorubicin—uterine cancer	2.99e-05	0.000223	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	2.97e-05	0.000221	CcSEcCtD
Ifosfamide—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	2.95e-05	0.00287	CbGpPWpGaD
Ifosfamide—Discomfort—Doxorubicin—uterine cancer	2.95e-05	0.00022	CcSEcCtD
Ifosfamide—Anorexia—Epirubicin—uterine cancer	2.95e-05	0.00022	CcSEcCtD
Ifosfamide—CYP2A6—Biological oxidations—CYP19A1—uterine cancer	2.94e-05	0.00286	CbGpPWpGaD
Ifosfamide—CYP3A5—Metapathway biotransformation—AKR1C3—uterine cancer	2.94e-05	0.00285	CbGpPWpGaD
Ifosfamide—CYP2C8—Metapathway biotransformation—GPX3—uterine cancer	2.9e-05	0.00282	CbGpPWpGaD
Ifosfamide—Hypotension—Epirubicin—uterine cancer	2.89e-05	0.000216	CcSEcCtD
Ifosfamide—Confusional state—Doxorubicin—uterine cancer	2.89e-05	0.000215	CcSEcCtD
Ifosfamide—Oedema—Doxorubicin—uterine cancer	2.86e-05	0.000214	CcSEcCtD
Ifosfamide—Anaphylactic shock—Doxorubicin—uterine cancer	2.86e-05	0.000214	CcSEcCtD
Ifosfamide—Infection—Doxorubicin—uterine cancer	2.85e-05	0.000212	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Epirubicin—uterine cancer	2.82e-05	0.00021	CcSEcCtD
Ifosfamide—Nervous system disorder—Doxorubicin—uterine cancer	2.81e-05	0.000209	CcSEcCtD
Ifosfamide—Thrombocytopenia—Doxorubicin—uterine cancer	2.8e-05	0.000209	CcSEcCtD
Ifosfamide—Skin disorder—Doxorubicin—uterine cancer	2.78e-05	0.000207	CcSEcCtD
Ifosfamide—Paraesthesia—Epirubicin—uterine cancer	2.78e-05	0.000207	CcSEcCtD
Ifosfamide—Hyperhidrosis—Doxorubicin—uterine cancer	2.77e-05	0.000206	CcSEcCtD
Ifosfamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	2.76e-05	0.00268	CbGpPWpGaD
Ifosfamide—Dyspnoea—Epirubicin—uterine cancer	2.76e-05	0.000206	CcSEcCtD
Ifosfamide—Somnolence—Epirubicin—uterine cancer	2.75e-05	0.000205	CcSEcCtD
Ifosfamide—CYP2C8—Biological oxidations—CYP11A1—uterine cancer	2.73e-05	0.00265	CbGpPWpGaD
Ifosfamide—Anorexia—Doxorubicin—uterine cancer	2.73e-05	0.000204	CcSEcCtD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.72e-05	0.00264	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.72e-05	0.00264	CbGpPWpGaD
Ifosfamide—CYP2C8—Metapathway biotransformation—CYP11A1—uterine cancer	2.7e-05	0.00262	CbGpPWpGaD
Ifosfamide—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	2.69e-05	0.00261	CbGpPWpGaD
Ifosfamide—Decreased appetite—Epirubicin—uterine cancer	2.69e-05	0.000201	CcSEcCtD
Ifosfamide—Hypotension—Doxorubicin—uterine cancer	2.68e-05	0.0002	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Epirubicin—uterine cancer	2.67e-05	0.000199	CcSEcCtD
Ifosfamide—Fatigue—Epirubicin—uterine cancer	2.67e-05	0.000199	CcSEcCtD
Ifosfamide—Constipation—Epirubicin—uterine cancer	2.65e-05	0.000197	CcSEcCtD
Ifosfamide—Pain—Epirubicin—uterine cancer	2.65e-05	0.000197	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	2.61e-05	0.000195	CcSEcCtD
Ifosfamide—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	2.6e-05	0.00253	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—SRD5A2—uterine cancer	2.6e-05	0.00252	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—NDUFB11—uterine cancer	2.6e-05	0.00252	CbGpPWpGaD
Ifosfamide—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	2.59e-05	0.00252	CbGpPWpGaD
Ifosfamide—Paraesthesia—Doxorubicin—uterine cancer	2.57e-05	0.000192	CcSEcCtD
Ifosfamide—Dyspnoea—Doxorubicin—uterine cancer	2.55e-05	0.00019	CcSEcCtD
Ifosfamide—Feeling abnormal—Epirubicin—uterine cancer	2.55e-05	0.00019	CcSEcCtD
Ifosfamide—Somnolence—Doxorubicin—uterine cancer	2.55e-05	0.00019	CcSEcCtD
Ifosfamide—CYP2C8—Metapathway biotransformation—AKR1C3—uterine cancer	2.55e-05	0.00247	CbGpPWpGaD
Ifosfamide—Gastrointestinal pain—Epirubicin—uterine cancer	2.53e-05	0.000189	CcSEcCtD
Ifosfamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	2.51e-05	0.00243	CbGpPWpGaD
Ifosfamide—Decreased appetite—Doxorubicin—uterine cancer	2.49e-05	0.000186	CcSEcCtD
Ifosfamide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	2.47e-05	0.0024	CbGpPWpGaD
Ifosfamide—Gastrointestinal disorder—Doxorubicin—uterine cancer	2.47e-05	0.000184	CcSEcCtD
Ifosfamide—Fatigue—Doxorubicin—uterine cancer	2.47e-05	0.000184	CcSEcCtD
Ifosfamide—Urticaria—Epirubicin—uterine cancer	2.46e-05	0.000183	CcSEcCtD
Ifosfamide—Pain—Doxorubicin—uterine cancer	2.45e-05	0.000183	CcSEcCtD
Ifosfamide—Constipation—Doxorubicin—uterine cancer	2.45e-05	0.000183	CcSEcCtD
Ifosfamide—Abdominal pain—Epirubicin—uterine cancer	2.45e-05	0.000182	CcSEcCtD
Ifosfamide—Body temperature increased—Epirubicin—uterine cancer	2.45e-05	0.000182	CcSEcCtD
Ifosfamide—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	2.44e-05	0.00237	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	2.43e-05	0.00236	CbGpPWpGaD
Ifosfamide—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	2.42e-05	0.00235	CbGpPWpGaD
Ifosfamide—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	2.41e-05	0.00234	CbGpPWpGaD
Ifosfamide—CYP2B6—Biological oxidations—CYP19A1—uterine cancer	2.38e-05	0.00231	CbGpPWpGaD
Ifosfamide—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	2.36e-05	0.00229	CbGpPWpGaD
Ifosfamide—Feeling abnormal—Doxorubicin—uterine cancer	2.36e-05	0.000176	CcSEcCtD
Ifosfamide—CYP2B6—Metapathway biotransformation—CYP19A1—uterine cancer	2.34e-05	0.00227	CbGpPWpGaD
Ifosfamide—Gastrointestinal pain—Doxorubicin—uterine cancer	2.34e-05	0.000175	CcSEcCtD
Ifosfamide—CYP3A5—Biological oxidations—CYP19A1—uterine cancer	2.32e-05	0.00225	CbGpPWpGaD
Ifosfamide—CYP3A5—Metapathway biotransformation—CYP19A1—uterine cancer	2.29e-05	0.00222	CbGpPWpGaD
Ifosfamide—Hypersensitivity—Epirubicin—uterine cancer	2.28e-05	0.00017	CcSEcCtD
Ifosfamide—Urticaria—Doxorubicin—uterine cancer	2.28e-05	0.00017	CcSEcCtD
Ifosfamide—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	2.27e-05	0.00221	CbGpPWpGaD
Ifosfamide—Abdominal pain—Doxorubicin—uterine cancer	2.26e-05	0.000169	CcSEcCtD
Ifosfamide—Body temperature increased—Doxorubicin—uterine cancer	2.26e-05	0.000169	CcSEcCtD
Ifosfamide—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	2.22e-05	0.00216	CbGpPWpGaD
Ifosfamide—Asthenia—Epirubicin—uterine cancer	2.22e-05	0.000166	CcSEcCtD
Ifosfamide—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	2.19e-05	0.00213	CbGpPWpGaD
Ifosfamide—Pruritus—Epirubicin—uterine cancer	2.19e-05	0.000163	CcSEcCtD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	2.17e-05	0.0021	CbGpPWpGaD
Ifosfamide—Diarrhoea—Epirubicin—uterine cancer	2.12e-05	0.000158	CcSEcCtD
Ifosfamide—Hypersensitivity—Doxorubicin—uterine cancer	2.11e-05	0.000157	CcSEcCtD
Ifosfamide—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	2.07e-05	0.00201	CbGpPWpGaD
Ifosfamide—Asthenia—Doxorubicin—uterine cancer	2.06e-05	0.000153	CcSEcCtD
Ifosfamide—Dizziness—Epirubicin—uterine cancer	2.05e-05	0.000153	CcSEcCtD
Ifosfamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	2.03e-05	0.00197	CbGpPWpGaD
Ifosfamide—Pruritus—Doxorubicin—uterine cancer	2.03e-05	0.000151	CcSEcCtD
Ifosfamide—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	2.01e-05	0.00195	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.99e-05	0.00194	CbGpPWpGaD
Ifosfamide—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	1.98e-05	0.00193	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	1.98e-05	0.00192	CbGpPWpGaD
Ifosfamide—Vomiting—Epirubicin—uterine cancer	1.97e-05	0.000147	CcSEcCtD
Ifosfamide—Diarrhoea—Doxorubicin—uterine cancer	1.96e-05	0.000146	CcSEcCtD
Ifosfamide—Rash—Epirubicin—uterine cancer	1.95e-05	0.000146	CcSEcCtD
Ifosfamide—Dermatitis—Epirubicin—uterine cancer	1.95e-05	0.000145	CcSEcCtD
Ifosfamide—Dizziness—Doxorubicin—uterine cancer	1.89e-05	0.000141	CcSEcCtD
Ifosfamide—CYP2C18—Metabolism—STAR—uterine cancer	1.88e-05	0.00182	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—AKR1B1—uterine cancer	1.88e-05	0.00182	CbGpPWpGaD
Ifosfamide—Nausea—Epirubicin—uterine cancer	1.84e-05	0.000137	CcSEcCtD
Ifosfamide—Vomiting—Doxorubicin—uterine cancer	1.82e-05	0.000136	CcSEcCtD
Ifosfamide—Rash—Doxorubicin—uterine cancer	1.81e-05	0.000135	CcSEcCtD
Ifosfamide—Dermatitis—Doxorubicin—uterine cancer	1.8e-05	0.000135	CcSEcCtD
Ifosfamide—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	1.8e-05	0.00174	CbGpPWpGaD
Ifosfamide—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	1.78e-05	0.00172	CbGpPWpGaD
Ifosfamide—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	1.77e-05	0.00172	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.75e-05	0.0017	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.75e-05	0.0017	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—SRD5A2—uterine cancer	1.73e-05	0.00168	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—NDUFB11—uterine cancer	1.73e-05	0.00168	CbGpPWpGaD
Ifosfamide—Nausea—Doxorubicin—uterine cancer	1.7e-05	0.000127	CcSEcCtD
Ifosfamide—PTGS1—Metabolism—SRD5A2—uterine cancer	1.67e-05	0.00162	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—NDUFB11—uterine cancer	1.67e-05	0.00162	CbGpPWpGaD
Ifosfamide—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	1.64e-05	0.00159	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.63e-05	0.00158	CbGpPWpGaD
Ifosfamide—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	1.61e-05	0.00157	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—SRD5A2—uterine cancer	1.58e-05	0.00154	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—NDUFB11—uterine cancer	1.58e-05	0.00154	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.57e-05	0.00152	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.57e-05	0.00152	CbGpPWpGaD
Ifosfamide—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	1.56e-05	0.00151	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.53e-05	0.00149	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—POLD1—uterine cancer	1.47e-05	0.00143	CbGpPWpGaD
Ifosfamide—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	1.47e-05	0.00142	CbGpPWpGaD
Ifosfamide—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	1.45e-05	0.0014	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.43e-05	0.00139	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.43e-05	0.00139	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—AKR1C1—uterine cancer	1.38e-05	0.00134	CbGpPWpGaD
Ifosfamide—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	1.37e-05	0.00133	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.29e-05	0.00125	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—SRD5A2—uterine cancer	1.28e-05	0.00124	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—NDUFB11—uterine cancer	1.28e-05	0.00124	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—AKR1B1—uterine cancer	1.25e-05	0.00121	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—STAR—uterine cancer	1.25e-05	0.00121	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—NDUFB11—uterine cancer	1.25e-05	0.00121	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—SRD5A2—uterine cancer	1.25e-05	0.00121	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—RRM2—uterine cancer	1.23e-05	0.00119	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—STAR—uterine cancer	1.21e-05	0.00117	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—AKR1B1—uterine cancer	1.21e-05	0.00117	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.2e-05	0.00116	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—DCN—uterine cancer	1.19e-05	0.00116	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.15e-05	0.00112	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—AKR1B1—uterine cancer	1.14e-05	0.00111	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—STAR—uterine cancer	1.14e-05	0.00111	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—CYP11A1—uterine cancer	1.12e-05	0.00109	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—NDUFB11—uterine cancer	1.08e-05	0.00105	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—SRD5A2—uterine cancer	1.08e-05	0.00105	CbGpPWpGaD
Ifosfamide—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.08e-05	0.00105	CbGpPWpGaD
Ifosfamide—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.06e-05	0.00103	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—AKR1C3—uterine cancer	1.06e-05	0.00103	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.05e-05	0.00102	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.05e-05	0.00102	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	9.91e-06	0.000962	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—POLD1—uterine cancer	9.79e-06	0.00095	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—SRD5A2—uterine cancer	9.65e-06	0.000936	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—NDUFB11—uterine cancer	9.65e-06	0.000936	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—POLD1—uterine cancer	9.49e-06	0.000921	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	9.37e-06	0.000909	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—AKR1B1—uterine cancer	9.23e-06	0.000896	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—STAR—uterine cancer	9.23e-06	0.000896	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—AKR1C1—uterine cancer	9.16e-06	0.000889	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—AKR1B1—uterine cancer	9.02e-06	0.000876	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—STAR—uterine cancer	9.02e-06	0.000876	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—POLD1—uterine cancer	8.98e-06	0.000871	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—AKR1C1—uterine cancer	8.88e-06	0.000862	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	8.85e-06	0.000859	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NDUFB11—uterine cancer	8.8e-06	0.000854	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SRD5A2—uterine cancer	8.8e-06	0.000854	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	8.54e-06	0.000829	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—AKR1C1—uterine cancer	8.4e-06	0.000815	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—STK11—uterine cancer	8.26e-06	0.000802	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—CYP19A1—uterine cancer	8.26e-06	0.000802	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—RRM2—uterine cancer	8.16e-06	0.000792	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	8.07e-06	0.000783	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—DCN—uterine cancer	7.93e-06	0.000769	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—RRM2—uterine cancer	7.91e-06	0.000768	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—STAR—uterine cancer	7.81e-06	0.000758	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—AKR1B1—uterine cancer	7.81e-06	0.000758	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	7.72e-06	0.00075	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—DCN—uterine cancer	7.68e-06	0.000746	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—RRM2—uterine cancer	7.48e-06	0.000726	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CYP11A1—uterine cancer	7.47e-06	0.000725	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—DCN—uterine cancer	7.26e-06	0.000705	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—POLD1—uterine cancer	7.24e-06	0.000703	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CYP11A1—uterine cancer	7.24e-06	0.000702	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—POLD1—uterine cancer	7.08e-06	0.000687	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—AKR1C3—uterine cancer	7.05e-06	0.000684	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—AKR1B1—uterine cancer	6.97e-06	0.000677	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—STAR—uterine cancer	6.97e-06	0.000677	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.89e-06	0.000669	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CYP11A1—uterine cancer	6.84e-06	0.000664	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—AKR1C3—uterine cancer	6.84e-06	0.000663	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—AKR1C1—uterine cancer	6.77e-06	0.000657	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—AKR1C1—uterine cancer	6.62e-06	0.000643	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—AKR1C3—uterine cancer	6.46e-06	0.000627	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—AKR1B1—uterine cancer	6.36e-06	0.000617	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—STAR—uterine cancer	6.36e-06	0.000617	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.29e-06	0.00061	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—MTHFR—uterine cancer	6.21e-06	0.000603	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—POLD1—uterine cancer	6.13e-06	0.000595	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—RRM2—uterine cancer	6.04e-06	0.000586	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—RRM2—uterine cancer	5.9e-06	0.000573	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—DCN—uterine cancer	5.86e-06	0.000569	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SRD5A2—uterine cancer	5.8e-06	0.000563	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NDUFB11—uterine cancer	5.8e-06	0.000563	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—AKR1C1—uterine cancer	5.73e-06	0.000557	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—DCN—uterine cancer	5.73e-06	0.000556	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYP11A1—uterine cancer	5.52e-06	0.000536	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—STK11—uterine cancer	5.49e-06	0.000533	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CYP19A1—uterine cancer	5.49e-06	0.000533	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—POLD1—uterine cancer	5.47e-06	0.000531	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP11A1—uterine cancer	5.4e-06	0.000524	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—STK11—uterine cancer	5.32e-06	0.000517	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CYP19A1—uterine cancer	5.32e-06	0.000517	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—AKR1C3—uterine cancer	5.21e-06	0.000506	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—AKR1C1—uterine cancer	5.12e-06	0.000497	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—RRM2—uterine cancer	5.11e-06	0.000496	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—AKR1C3—uterine cancer	5.1e-06	0.000495	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—STK11—uterine cancer	5.04e-06	0.000489	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CYP19A1—uterine cancer	5.04e-06	0.000489	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5e-06	0.000485	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—POLD1—uterine cancer	4.99e-06	0.000484	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—DCN—uterine cancer	4.96e-06	0.000482	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.77e-06	0.000463	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP11A1—uterine cancer	4.68e-06	0.000454	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—AKR1C1—uterine cancer	4.67e-06	0.000453	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—RRM2—uterine cancer	4.56e-06	0.000443	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—DCN—uterine cancer	4.43e-06	0.00043	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—AKR1C3—uterine cancer	4.42e-06	0.000429	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—STAR—uterine cancer	4.19e-06	0.000407	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—AKR1B1—uterine cancer	4.19e-06	0.000407	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP11A1—uterine cancer	4.17e-06	0.000405	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—RRM2—uterine cancer	4.16e-06	0.000404	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—MTHFR—uterine cancer	4.13e-06	0.000401	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—STK11—uterine cancer	4.06e-06	0.000394	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYP19A1—uterine cancer	4.06e-06	0.000394	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—DCN—uterine cancer	4.04e-06	0.000392	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—MTHFR—uterine cancer	4e-06	0.000388	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—STK11—uterine cancer	3.97e-06	0.000385	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP19A1—uterine cancer	3.97e-06	0.000385	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—AKR1C3—uterine cancer	3.94e-06	0.000382	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP11A1—uterine cancer	3.8e-06	0.000369	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—MTHFR—uterine cancer	3.78e-06	0.000367	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—AKR1C3—uterine cancer	3.59e-06	0.000349	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.53e-06	0.000342	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PTEN—uterine cancer	3.45e-06	0.000335	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—STK11—uterine cancer	3.44e-06	0.000334	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP19A1—uterine cancer	3.44e-06	0.000334	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—EP300—uterine cancer	3.29e-06	0.00032	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—POLD1—uterine cancer	3.29e-06	0.000319	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.23e-06	0.000313	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.08e-06	0.000299	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—AKR1C1—uterine cancer	3.08e-06	0.000299	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—STK11—uterine cancer	3.07e-06	0.000298	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP19A1—uterine cancer	3.07e-06	0.000298	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—MTHFR—uterine cancer	3.05e-06	0.000296	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—MTHFR—uterine cancer	2.98e-06	0.00029	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.88e-06	0.00028	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP19A1—uterine cancer	2.8e-06	0.000272	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—STK11—uterine cancer	2.8e-06	0.000272	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.75e-06	0.000267	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—RRM2—uterine cancer	2.74e-06	0.000266	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—DCN—uterine cancer	2.66e-06	0.000259	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.63e-06	0.000255	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—MTHFR—uterine cancer	2.58e-06	0.000251	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.51e-06	0.000244	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.51e-06	0.000243	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CA—uterine cancer	2.44e-06	0.000237	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.37e-06	0.00023	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—MTHFR—uterine cancer	2.31e-06	0.000224	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTEN—uterine cancer	2.3e-06	0.000223	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.28e-06	0.000221	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PTEN—uterine cancer	2.23e-06	0.000216	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—EP300—uterine cancer	2.19e-06	0.000213	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—EP300—uterine cancer	2.12e-06	0.000206	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTEN—uterine cancer	2.11e-06	0.000204	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—MTHFR—uterine cancer	2.1e-06	0.000204	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.03e-06	0.000197	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—EP300—uterine cancer	2.01e-06	0.000195	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—AKT1—uterine cancer	1.99e-06	0.000193	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.85e-06	0.00018	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—STK11—uterine cancer	1.85e-06	0.000179	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.85e-06	0.000179	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTEN—uterine cancer	1.7e-06	0.000165	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTEN—uterine cancer	1.66e-06	0.000161	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CA—uterine cancer	1.62e-06	0.000157	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—EP300—uterine cancer	1.62e-06	0.000157	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—EP300—uterine cancer	1.58e-06	0.000154	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CA—uterine cancer	1.57e-06	0.000152	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CA—uterine cancer	1.49e-06	0.000144	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTEN—uterine cancer	1.44e-06	0.00014	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—MTHFR—uterine cancer	1.39e-06	0.000135	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—EP300—uterine cancer	1.37e-06	0.000133	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—AKT1—uterine cancer	1.32e-06	0.000128	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTEN—uterine cancer	1.28e-06	0.000125	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—AKT1—uterine cancer	1.28e-06	0.000125	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—EP300—uterine cancer	1.22e-06	0.000119	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—AKT1—uterine cancer	1.21e-06	0.000118	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CA—uterine cancer	1.2e-06	0.000116	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CA—uterine cancer	1.17e-06	0.000114	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTEN—uterine cancer	1.17e-06	0.000114	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—EP300—uterine cancer	1.12e-06	0.000108	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CA—uterine cancer	1.01e-06	9.85e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—AKT1—uterine cancer	9.79e-07	9.5e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—AKT1—uterine cancer	9.57e-07	9.29e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CA—uterine cancer	9.05e-07	8.79e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—AKT1—uterine cancer	8.29e-07	8.04e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CA—uterine cancer	8.26e-07	8.01e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTEN—uterine cancer	7.72e-07	7.49e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—AKT1—uterine cancer	7.4e-07	7.18e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—EP300—uterine cancer	7.36e-07	7.14e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—AKT1—uterine cancer	6.74e-07	6.55e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CA—uterine cancer	5.44e-07	5.28e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—AKT1—uterine cancer	4.45e-07	4.32e-05	CbGpPWpGaD
